Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $45.55 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

Earnings

Ironwood Pharmaceuticals (IRWD) Costs Increase to Offset Revenue Upside - WedbushFebruary 19, 2016 9:51 AM Mizuho Securities Reiterates Buy Following Ironwood Pharma's (IRWD) Strong 4Q Results February 19, 2016 9:30 AM BTIG Sees Opportunity in Ironwood Pharma (IRWD) Weakness; Affirms at 'Buy'February 19, 2016 7:50 AM Leerink Partners Remains Sidelined After Ironwood Pharma's (IRWD) 4Q February 19, 2016 7:22 AM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor UpdateFebruary 18, 2016 4:05 PM